KRAS and lung adenocarcinoma: In the present study, we describe the molecular epidemiology of EGFR, KRAS, BRAF, ALK and MET genetic alterations and their correlations with the demographic and clinical characteristics of 1440 Sardinian patients with lung adenocarcinoma.